News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dube Eric M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Dube Eric M (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 6,442 shares
@ $21.5, valued at
$138.5k
|
|
| 01/06/2023 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 5,625 shares
@ $20.75, valued at
$116.7k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 37,848 shares
@ $0
Sold 4,813 shares
@ $27.4, valued at
$131.9k
Granted 169,552 options to buy
@ $27.5, valued at
$4.7M
Granted 37,848 options to buy
@ $0 |
|
| 01/26/2022 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 7,873 shares
@ $24.98, valued at
$196.7k
|
|
| 01/06/2022 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 4,832 shares
@ $30.43, valued at
$147k
Sold 10,361 shares
@ $29.84, valued at
$309.2k
Sold 2,139 shares
@ $30.48, valued at
$65.2k
|
|
| 06/03/2021 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 4,782 shares
@ $14.89, valued at
$71.2k
Sold 4,780 shares
@ $14.35, valued at
$68.6k
|
|
| 02/09/2021 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 4,813 shares
@ $31.41, valued at
$151.2k
Sold 4,813 shares
@ $31.58, valued at
$152k
|
|
| 02/05/2021 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 17,500 shares
@ $0 |
|
| 02/03/2021 |
4
| Dube Eric M (CEO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 2,406 shares
@ $28.91, valued at
$69.6k
|
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2020 |
4
| Dube Eric M (CEO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 3,000 shares
@ $0
Sold 9,240 shares
@ $19.2785, valued at
$178.1k
Sold 1,565 shares
@ $19.2882, valued at
$30.2k
|
|
| 01/31/2020 |
4
| Dube Eric M (CEO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 35,000 shares
@ $0
Granted 300,000 options to buy
@ $15.46, valued at
$4.6M
Granted 35,000 options to buy
@ $0
Granted 30,000 options to buy
@ $0 |
|
| 01/08/2020 |
4
| Dube Eric M (CEO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 3,750 shares
@ $13.94, valued at
$52.3k
Sold 3,750 shares
@ $15.14, valued at
$56.8k
|
|
| 05/10/2019 |
4
| Dube Eric M (CEO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 6,000 options to buy
@ $0 |
|
| 01/08/2019 |
4
| Dube Eric M (CEO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 400,000 options to buy
@ $23.34, valued at
$9.3M
Granted 50,000 options to buy
@ $0 |
|
|
|